According to GLOBOCAN 2022 estimates, 21,628 women in Thailand were newly diagnosed with breast cancer in 2022, making it the most commonly diagnosed cancer among Thai women, accounting for 23.2% of new cancer cases among women that year.
Serava is a breast cancer awareness and preliminary risk assessment tool designed to help people understand their breast cancer risk and encourage them to seek medical advice when appropriate. The survey is adapted from the Gail Model, a commonly used breast cancer risk assessment model. It is intended as an educational and preliminary risk awareness tool, not a medical diagnosis.
As Lead Programmer, Adaaran develops and improves the digital survey, including its logic, scoring system, and user experience, with a focus on making it accessible to people from different communities.
"I was inspired to start Serava because breast cancer is an important health issue in Thailand, and I wanted to use technology to make breast cancer risk awareness more accessible," Adaaran shared. "I saw an opportunity to combine programming with community outreach to create a tool that could encourage people to learn more about their health and take the next step toward professional screening when appropriate."
Since launching, around 300 people have completed Serava's survey. Adaaran has also traveled to different parts of Thailand to introduce communities to the project firsthand. Through this outreach, he has seen how technology becomes more meaningful when connected to service and real human needs.
Serava is currently partnering with Sabina to expand its reach.
Through the IB programme and ISB's community service opportunities, Adaaran has been encouraged to think beyond the classroom and use his skills to support others turning Serava from an idea into an ongoing community project.
"Serava is still an ongoing project, and I am continuing to improve the technology, expand its reach, and develop partnerships that can help the project have a greater impact in communities across Thailand," Adaaran said.